Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75a4811e7eae15e0f1e32cc6a222ce30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 |
filingDate |
2007-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32128a4ec3401c8b2baa9946ca0fdf5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0cf6b4ad6baccaf84440b600b4fffb8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2357f436cd7b54ce627c9e340a25ce2c |
publicationDate |
2011-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
NZ-571975-A |
titleOfInvention |
Neurogenesis inducer or neuropathy therapeutic agent comprising benzothiopene alkyl ether derivative or salt thereof |
abstract |
Disclosed is the use of a benzothiophene alkyl ether derivative represented by the general formula depicted for use as a neurogenesis inducer and for treating mental disorders such as schizophrenia. Also disclosed is the use of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol for treating said diseases. |
priorityDate |
2006-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |